FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2969403770> ?p ?o ?g. }

• W2969403770 endingPage "231" @default.
• W2969403770 startingPage "219" @default.
• W2969403770 abstract "Non-small-cell lung cancer (NSCLC) is one of the deadliest cancers in the world. Circular RNA (circRNA) has been shown to participate in oncogenesis regulation, including lung cancer. Although the involvement of circRNAs in lung cancer has been reported, the regulatory mechanisms of circRNAs in NSCLC remain poorly understood. Thus, the present study aims at investigating the role of circARHGAP10 in NSCLC progression, which has been observed to be significantly upregulated in both NSCLC tissues and cell lines with profile analysis. A higher expression of circARHGAP10 also leads to a poor prognosis in NSCLC patients with fluorescence in situ hybridization (FISH). Both in vitro and in vivo experiments found that the downregulation of circARHGAP10 suppressed glycometabolism by decreasing GLUT1 expression. Silencing circARHGAP10 also suppressed proliferation and metastasis by targeting the miR-150-5p/GLUT1 axis in NSCLC, which was confirmed with a luciferase reporter assay. Overexpression of GLUT1 or downregulation miR-150-5p will recover NSCLC cell proliferation and metastasis after a knockdown of circARHGAP10. Taken together, these findings demonstrate that circARHGAP10 suppresses NSCLC progression by acting as a miR-150-5p sponge to promote GLUT1 expression. Thus, circARHGAP10 may be a potential target for NSCLC treatment. Non-small-cell lung cancer (NSCLC) is one of the deadliest cancers in the world. Circular RNA (circRNA) has been shown to participate in oncogenesis regulation, including lung cancer. Although the involvement of circRNAs in lung cancer has been reported, the regulatory mechanisms of circRNAs in NSCLC remain poorly understood. Thus, the present study aims at investigating the role of circARHGAP10 in NSCLC progression, which has been observed to be significantly upregulated in both NSCLC tissues and cell lines with profile analysis. A higher expression of circARHGAP10 also leads to a poor prognosis in NSCLC patients with fluorescence in situ hybridization (FISH). Both in vitro and in vivo experiments found that the downregulation of circARHGAP10 suppressed glycometabolism by decreasing GLUT1 expression. Silencing circARHGAP10 also suppressed proliferation and metastasis by targeting the miR-150-5p/GLUT1 axis in NSCLC, which was confirmed with a luciferase reporter assay. Overexpression of GLUT1 or downregulation miR-150-5p will recover NSCLC cell proliferation and metastasis after a knockdown of circARHGAP10. Taken together, these findings demonstrate that circARHGAP10 suppresses NSCLC progression by acting as a miR-150-5p sponge to promote GLUT1 expression. Thus, circARHGAP10 may be a potential target for NSCLC treatment." @default.
• W2969403770 created "2019-08-29" @default.
• W2969403770 creator A5016091734 @default.
• W2969403770 creator A5029546135 @default.
• W2969403770 creator A5048295765 @default.
• W2969403770 creator A5053576258 @default.
• W2969403770 creator A5061972961 @default.
• W2969403770 date "2019-12-01" @default.
• W2969403770 modified "2023-10-17" @default.
• W2969403770 title "Upregulated circRNA ARHGAP10 Predicts an Unfavorable Prognosis in NSCLC through Regulation of the miR-150-5p/GLUT-1 Axis" @default.
• W2969403770 cites W1991082489 @default.
• W2969403770 cites W2008976996 @default.
• W2969403770 cites W2034305079 @default.
• W2969403770 cites W2058835062 @default.
• W2969403770 cites W2064165694 @default.
• W2969403770 cites W2097259163 @default.
• W2969403770 cites W2102748761 @default.
• W2969403770 cites W2184779060 @default.
• W2969403770 cites W2266356262 @default.
• W2969403770 cites W2617429347 @default.
• W2969403770 cites W2772152366 @default.
• W2969403770 cites W2796920078 @default.
• W2969403770 cites W2797332465 @default.
• W2969403770 cites W2809581434 @default.
• W2969403770 cites W2809857861 @default.
• W2969403770 cites W2883299188 @default.
• W2969403770 cites W2885489257 @default.
• W2969403770 cites W2888475832 @default.
• W2969403770 cites W2890456323 @default.
• W2969403770 cites W2893742563 @default.
• W2969403770 cites W2893792076 @default.
• W2969403770 cites W2895298348 @default.
• W2969403770 cites W2897240874 @default.
• W2969403770 cites W2900858658 @default.
• W2969403770 cites W2901125032 @default.
• W2969403770 cites W2901270514 @default.
• W2969403770 cites W2901528543 @default.
• W2969403770 cites W2906071128 @default.
• W2969403770 cites W2907710771 @default.
• W2969403770 cites W2917245118 @default.
• W2969403770 cites W4240367950 @default.
• W2969403770 doi "https://doi.org/10.1016/j.omtn.2019.08.016" @default.
• W2969403770 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6796700" @default.
• W2969403770 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31561126" @default.
• W2969403770 hasPublicationYear "2019" @default.
• W2969403770 type Work @default.
• W2969403770 sameAs 2969403770 @default.
• W2969403770 citedByCount "57" @default.
• W2969403770 countsByYear W29694037702019 @default.
• W2969403770 countsByYear W29694037702020 @default.
• W2969403770 countsByYear W29694037702021 @default.
• W2969403770 countsByYear W29694037702022 @default.
• W2969403770 countsByYear W29694037702023 @default.
• W2969403770 crossrefType "journal-article" @default.
• W2969403770 hasAuthorship W2969403770A5016091734 @default.
• W2969403770 hasAuthorship W2969403770A5029546135 @default.
• W2969403770 hasAuthorship W2969403770A5048295765 @default.
• W2969403770 hasAuthorship W2969403770A5053576258 @default.
• W2969403770 hasAuthorship W2969403770A5061972961 @default.
• W2969403770 hasBestOaLocation W29694037701 @default.
• W2969403770 hasConcept C104317684 @default.
• W2969403770 hasConcept C119056186 @default.
• W2969403770 hasConcept C121608353 @default.
• W2969403770 hasConcept C126322002 @default.
• W2969403770 hasConcept C127561419 @default.
• W2969403770 hasConcept C143998085 @default.
• W2969403770 hasConcept C145059251 @default.
• W2969403770 hasConcept C173396325 @default.
• W2969403770 hasConcept C2775893923 @default.
• W2969403770 hasConcept C2776256026 @default.
• W2969403770 hasConcept C2779013556 @default.
• W2969403770 hasConcept C2779256057 @default.
• W2969403770 hasConcept C502942594 @default.
• W2969403770 hasConcept C54355233 @default.
• W2969403770 hasConcept C555283112 @default.
• W2969403770 hasConcept C71924100 @default.
• W2969403770 hasConcept C81885089 @default.
• W2969403770 hasConcept C86803240 @default.
• W2969403770 hasConceptScore W2969403770C104317684 @default.
• W2969403770 hasConceptScore W2969403770C119056186 @default.
• W2969403770 hasConceptScore W2969403770C121608353 @default.
• W2969403770 hasConceptScore W2969403770C126322002 @default.
• W2969403770 hasConceptScore W2969403770C127561419 @default.
• W2969403770 hasConceptScore W2969403770C143998085 @default.
• W2969403770 hasConceptScore W2969403770C145059251 @default.
• W2969403770 hasConceptScore W2969403770C173396325 @default.
• W2969403770 hasConceptScore W2969403770C2775893923 @default.
• W2969403770 hasConceptScore W2969403770C2776256026 @default.
• W2969403770 hasConceptScore W2969403770C2779013556 @default.
• W2969403770 hasConceptScore W2969403770C2779256057 @default.
• W2969403770 hasConceptScore W2969403770C502942594 @default.
• W2969403770 hasConceptScore W2969403770C54355233 @default.
• W2969403770 hasConceptScore W2969403770C555283112 @default.
• W2969403770 hasConceptScore W2969403770C71924100 @default.
• W2969403770 hasConceptScore W2969403770C81885089 @default.
• W2969403770 hasConceptScore W2969403770C86803240 @default.
• W2969403770 hasFunder F4320321001 @default.
• W2969403770 hasFunder F4320328940 @default.

• next